All Releases
 |
Data on VIVUS' Qnexa(R) To Be Presented at the National Medical Association Annual Assembly
Jul 29, 2010
|
10.7 KB |
|
| |
MOUNTAIN VIEW, Calif., July 29, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be presented at the 2010 National Medical Association Annual Convention & Scientific Assembly (NMA), being held from July 31 - August 4, 2010 in Orlando, Florida. Dr....
|
|
VIVUS Announces Date of Second Quarter 2010 Financial Results and Conference Call
Jul 29, 2010
|
9.6 KB |
|
| |
MOUNTAIN VIEW, Calif., Jul 29, 2010 (GlobeNewswire via COMTEX News Network) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the second quarter ended June 30, 2010 after the NASDAQ Market closes on Monday, August 2, 2010.
The company will discuss financial results and provide a business update through a con...
|
|
VIVUS Comments on FDA Advisory Committee Panel Meeting on QNEXA(R) (phentermine/topiramate) Controlled Release Capsules for the Treatment of Obesity
Jul 15, 2010
|
11.3 KB |
|
| |
MOUNTAIN VIEW, Calif., July 15, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk asse...
|
|
Data on VIVUS' Qnexa to be Presented at International Congress on Obesity
Jul 12, 2010
|
10.8 KB |
|
| |
MOUNTAIN VIEW, Calif., July 12, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be presented at the 11th International Congress on Obesity (ICO) in Stockholm, Sweden. Kishore Gadde, MD, director of obesity clinical trials at Duke University, will ...
|
|
Six Presentations at the ADA Annual Meeting will Highlight Data on VIVUS' Qnexa
Jun 22, 2010
|
12.9 KB |
|
| |
MOUNTAIN VIEW, Calif., June 22, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be featured in a total of six presentations - including an oral presentation, three moderated poster presentations and two poster presentations - during the 70th Scien...
|
|
Endocrine Society's Annual Meeting to Feature Data on VIVUS' Qnexa
Jun 16, 2010
|
10.8 KB |
|
| |
MOUNTAIN VIEW, Calif., June 16, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be presented at the Endocrine Society's 92nd Annual Meeting and Expo (ENDO) in San Diego, California. Timothy Garvey, M.D., professor of medicine and chair of the depa...
|
|
Positive Results From Phase 2 Study of Qnexa in Obstructive Sleep Apnea Presented at Sleep Meeting
Jun 8, 2010
|
15.4 KB |
|
| |
MOUNTAIN VIEW, Calif., June 8, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data from a previously reported phase 2 study evaluating the safety and efficacy of the investigational drug Qnexa(R) for the treatment of obstructive sleep apnea (OSA) were presented at SLEEP 2010, the 24th Annual Meeting of ...
|
|
VIVUS Announces Positive Results From Phase 3 Study of Avanafil in Diabetics With Erectile Dysfunction
Jun 7, 2010
|
13.6 KB |
|
| |
MOUNTAIN VIEW, Calif., June 7, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced positive results from the phase 3 REVIVE-Diabetes (TA-302) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED) in men with type 1 and type 2 diabetes. The RE...
|
|
VIVUS to Present at Three Upcoming Investor Conferences
Jun 4, 2010
|
9.3 KB |
|
| |
MOUNTAIN VIEW, Calif., June 4, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that VIVUS management will present an overview of the company at three investment conferences during the month of June.
The conference presentation schedule is as follows:
The 9(th) Annual Needham Healthcare
...
|
|
Positive Results From Phase 3 Study of Avanafil in Erectile Dysfunction Presented at AUA Annual Meeting
Jun 1, 2010
|
14.6 KB |
|
| |
MOUNTAIN VIEW, Calif., June 1, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data from the previously reported phase 3 pivotal REVIVE (TA-301) study, evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED), were presented at the American Ur...
|
|
Phase 3 Data on VIVUS' Avanafil for Erectile Dysfunction to be Featured at the AUA 2010 Annual Meeting
May 28, 2010
|
11.1 KB |
|
| |
MOUNTAIN VIEW, Calif., May 28, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that phase 3 data on avanafil, a next generation oral phosphodiesterase type 5 (PDE5) inhibitor therapy being investigated for the treatment of erectile dysfunction (ED), will be presented next Tuesday at the American Urological As...
|
|
Data on VIVUS' Qnexa to be Featured at World Congress Highlighting Metabolic Disease and Related Disorders
May 13, 2010
|
10.7 KB |
|
| |
MOUNTAIN VIEW, Calif., May 13, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be presented at the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) in Prague, Czech Republic. Timothy Garvey, MD, profes...
|
|
VIVUS To Present at Four Upcoming Investor Conferences
May 10, 2010
|
9.4 KB |
|
| |
MOUNTAIN VIEW, Calif., May 10, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that VIVUS management will present an overview of the company at four investment conferences during the month of May.
The conference presentation schedule is as follows:
The Ninth Annual JMP Securities Research Co...
|
|
Data on VIVUS' Qnexa to be Presented at European Congress Focused on Cardiovascular Prevention and Rehabilitation
May 5, 2010
|
11.2 KB |
|
| |
MOUNTAIN VIEW, Calif., May 5, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that new data on Qnexa(R), an investigational drug candidate, will be presented at EuroPRevent 2010, the annual congress of the European Association for Cardiovascular Prevention and Rehabilitation, organized by the European Society...
|
|
VIVUS Grants Stock Option to New Senior Vice President and Chief Commercial Officer
May 4, 2010
|
10.3 KB |
|
| |
MOUNTAIN VIEW, Calif., May 4, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that, in accordance with NASDAQ Listing Rule 5635, Michael P. Miller, the Company's new senior vice president and chief commercial officer, was granted an Inducement Grant by the Company's Board of Directors on April 30, 2010. This...
|
|
VIVUS Reports First Quarter 2010 Financial Results
May 3, 2010
|
16.7 KB |
|
| |
MOUNTAIN VIEW, Calif., May 3, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today reported its highlights and financial results for the first quarter ended March 31, 2010.
First Quarter 2010 Highlights
On Januar...
|
|
VIVUS Appoints Michael Miller to Senior Vice President and Chief Commercial Officer
May 3, 2010
|
10.8 KB |
|
| |
MOUNTAIN VIEW, Calif., May 3, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced the appointment of Michael P. Miller to the position of senior vice president and chief commercial officer. This newly created position, reporting directly to Leland Wilson, chief executive officer, will be responsible for building ...
|
|
VIVUS To Present at Deutsche Bank 35th Annual Healthcare Conference
Apr 29, 2010
|
8.4 KB |
|
| |
MOUNTAIN VIEW, Calif., April 29, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that Timothy Morris, chief financial officer, will present an overview of the company at the Deutsche Bank 35th Annual Healthcare Conference.
The VIVUS presentation will take place at the InterContinental Boston in Boston, Massa...
|
|
Data on VIVUS' Qnexa To Be Featured at the American Society of Hypertension Annual Meeting
Apr 28, 2010
|
11.1 KB |
|
| |
MOUNTAIN VIEW, Calif., April 28, 2010 /PRNewswire via COMTEX News Network/ -- VIVUS, Inc. (Nasdaq: VVUS) today announced that data on Qnexa(R), an investigational drug candidate, will be presented at the American Society of Hypertension 25th Annual Scientific Meeting and Exposition in New York, NY. Suzanne Oparil, MD, professor of medicine, physiol...
|
|
VIVUS Announces Date of First Quarter 2010 Financial Results and Conference Call
Apr 27, 2010
|
10.2 KB |
|
| |
MOUNTAIN VIEW, Calif., Apr 27, 2010 (GlobeNewswire via COMTEX News Network) -- VIVUS, Inc. (Nasdaq:VVUS) today announced that it will report financial results for the first quarter ended March 31, 2010 after the NASDAQ Market closes on Monday, May 3, 2010.
The company will conduct a conference call and an audio webcast at 1:30pm PT on the same ...
|
|
|
= add release to Briefcase |
Shareholder Briefcase
Email Alerts
Download Library
RSS News Feeds